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Key Points
• Laparoscopic antireflux surgery (LARS) is associated with gas-related complications that may be due to the
inability to belch. Objective data on the effect of LARS on belching are currently not available in children with
GERD.
• LARS significantly reduced the number of gastric belches (GBs), whereas the number of air swallows and
supragastric belches (SGBs) remains unchanged.
• The reduction in gastric belching is likely to explain frequently reported postoperative gas-related complica-
tions of LARS in children.
Abstract
Background Laparoscopic antireflux surgery (LARS) is
a well-established treatment option for children with
proton pomp inhibitor (PPI)-resistant gastroe-
sophageal reflux disease (GERD). Besides preventing
reflux of gastric fluid and solid content, LARS may
also impair the ability of the stomach to vent intra-
gastric air (i.e. gastric belching) and induce gas-related
complications, such as bloating and/or hyperflatu-
lence. Furthermore, it was previously hypothesized
that LARS induces a behavioral type of belching, not
originating from the stomach, called supragastric
belching. The aim of this study was to objectively
evaluate the impact of LARS on gastric (GB) and
supragastric belching (SGB) in children with GERD.
MethodsWe performed a prospective, Dutch multicen-
ter cohort study including 25 patients (12 males,
median age 6 (range 2–18) years) with PPI-resistant
GERD who were scheduled for LARS. Twenty-four-
hour multichannel intraluminal impedance pH moni-
toring (MII-pH monitoring) was performed before and
3 months after fundoplication. Impedance pH tracings
were analyzed for reflux episodes and GBs and SGBs.
Key Results LARS reduced acid exposure time from
8.5% (6.0–16.2%) to 0.8% (0.2–2.8%), p < 0.001. The
number of GBs also significantly decreased after LARS
(59 [43–77] VS 5 [2–12], p < 0.001). The number of air
swallows remained unchanged after LARS. SGBs were
infrequent before LARS with no change in the number
of SGB observed after the procedure. Postoperative
belching symptomswere associatedwithGBs, notwith
SGBs. Conclusion & Inferences LARS significantly
reduces the number of GBs in children with GERD,
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whereas the number of air swallows remains
unchanged. Postoperative symptomatic belching is
associatedwithGBs, but notwith SGBs. These findings
suggest that LARS does not induce the occurrence of
SGBs in children, but longer follow-up is required.
Keywords belching, gas, gastroesophageal reflux dis-
ease, laparoscopic fundoplication, pediatrics.
Abbreviations: EGJ, esophagogastric junction; GB, gas-
tric belch; GER, gastroesophageal reflux; GERD, gas-
troesophageal reflux disease; GSQ, Gastroesophageal
Reflux Symptom Questionnaire; LARS, laparoscopic
antireflux surgery; MII, multichannel intraluminal
impedance; SGB, supragastric belch; TLESR, transient
lower esophageal sphincter relaxation.
INTRODUCTION
The esophagogastric junction (EGJ), composed of the
lower esophageal sphincter and crural diaphragm, serves
as a physiological barrier that allows the antegrade
passage of food and fluids during swallowing, whereas
preventing retrograde passage (reflux) of gastric content
into the esophagus.1 Furthermore, the EGJ mediates
gastric belching via transient lower esophageal sphinc-
ter relaxation (TLESR). These relaxations are elicited by
distention of the gastric fundus and are vital for venting
of accumulated intragastric air, ingested with food or
during speech.2,3 In children with gastroesophageal
reflux disease (GERD), the barrier function of the EGJ
is impaired and reflux of gastric content into the
esophagus is no longer prevented. Most reflux episodes
in children occur during these TLESRs.4–6
Laparoscopic antireflux surgery (LARS) is a well-
established treatment option for proton pomp inhibitor
(PPI) therapy-resistant GERD in children.7 By wrapping
the gastric fundus around the lower esophageal sphinc-
ter LARS aims to reinforce the barrier function of the
EGJ and prevent reflux episodes. In previous studies it
has been shown that LARS effectively reduces reflux
episodes in adults mainly by a reduction in the number
of TLESRs and its association with reflux episodes.8,9
However, by reducing the TLESRs, LARS may also
impair the physiologic ability to belch and induce
postprocedural gas-related symptoms. Previous studies
in adults after LARS have demonstrated an impaired
belching response during gastric air infusion and a
remarkable reduction in the number of postoperative
gastric belches (GBs) on24-hmultichannel intraluminal
impedance-pH (MII-pH).10–12 The inability to vent gas-
tric air post-LARS may lead to gas-related symptoms,
such as gas bloating or the inability to belch, which are
common complaints after this procedure in adults.13,14
Furthermore, 24-h MII-pH tracings also revealed a
significant increase in the number of supragastric
belches (SGBs). This alternative belching mechanism
is behavioral and can be differentiated fromGBs as air is
sucked into the esophagus and immediately (within a
second) expelled againwithout entering the stomach.15–
17 It was previously hypothesized that the increase in
SGBs after LARS is a response to gas bloating, inducedby
the decrease in GBs and the unaltered rate in air
swallows after LARS. The act of supragastric belching,
despite no air is vented from the stomach, may alleviate
postoperative gas bloating as patientsmay not be able to
discriminate between GBs and SGBs.11
Studies on LARS in the pediatric population report
the inability to belch in up to 19%of patients 18 and gas-
bloat syndrome in up to 11% of patients.18–20 However,
objective data on the effect of LARS on belching and a
possible increase in supragastric belching have not been
reported.The aimof this study is therefore to objectively
evaluate the impact of LARS on belching pattern in
childrenwithGERD.Wehypothesize that similar to the




This study contains a post hoc analysis of a prospective multi-
center study evaluating the efficacy and safety of laparoscopic
antireflux surgery in children in three University Medical Centers
in the Netherlands that are specialized in performing fundoplica-
tion in children (Wilhelmina children’s Hospital, University
Medical Center Utrecht [UMCU]; Sophia’s Childrens Hospital,
Erasmus University Medical Center [Erasmus MC]; and Maas-
tricht University Medical Center [MUMC]). From July 2011 until
December 2013, patients diagnosed with PPI therapy-resistant
GERD were prospectively included. Patients who underwent
previous esophageal or gastric surgery (except previous gastros-
tomy placement) and those with anatomical abnormalities other
than esophageal hiatal hernia were excluded. These patients were
evaluated before and 3 months after the surgical procedure.
Patients
In total 25 children were included in our study. Mean age of the
included patients was 6 (range 2–18) years at the time of
fundoplication (Table 1). Five children (80%) had normal neu-
rodevelopment (NN), whereas impaired neurodevelopment (NI)
was seen in five children (20%). Underlying diseases causing NI
are also shown in Table 1.
Surgical procedure
Experienced pediatric surgeons performed the laparoscopic fun-
doplications. In the UMC Utrecht, the anterior, partial
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fundoplication according to Thal21 was used to perform fundopli-
cation. In the other two centers (Erasmus MC and Maastricht
UMC), the posterior, total fundoplication according to Nissen22
was performed. Before fundoplication, the distal esophagus was
fully mobilized; the distal 3 cm of the esophagus was reposi-
tioned back into the abdomen. Furthermore, in the UMCU and
EMC, both vagal nerves were identified, and a cruroplasty was
routinely performed. Thereafter, the fundoplication was con-
structed. The Thal fundoplication was performed by plication of
the fundus of the stomach over 270 °C against the distal anterior
intra-abdominal part of the esophagus and the diaphragmatic
crus.23 A floppy Nissen was constructed with one of the sutures
of the 360 °C posterior wrap incorporated into the esophageal
wall.22
Ambulatory 24-h multichannel intraluminal
impedance pH monitoring
Ambulatory 24-h MII-pH testing was conducted after at least
3 days cessation of all medications that affect gastrointestinal
motility and/or acid secretion. Measurements were performed
using an age-adjusted combined pH–impedance catheter assem-
bly that consisted of six impedance segments and one ISFET pH
electrode (Unisensor AG, Attikon, Switzerland). Impedance and
pH signals were stored on a digital datalogger (Ohmega, Medical
Measurement Systems, Enschede, The Netherlands), using a
sampling frequency of 50 Hz. Patients and/or their parents were
instructed to continue their regular diet, to report GERD
symptoms, and to keep a diary of their consumptions and body
position (supine or upright) during the measurement.
Reflux-specific questionnaires
To assess belching symptoms patients and/or their parents were
asked to fill out the validated age-adjusted Gastroesophageal
Reflux Symptom Questionnaire (GSQ) before and 3 months after
LARS.24 Patients and/or their parents monitored belching symp-
toms during the week before and including the day of MII-pH
monitoring. The time interval before surgery ranged between
1 week and 2 months. Postoperative symptom assessment was
performed 3 months after surgery. Belching symptoms were
scored for frequency and severity on a score ranging from 1 (none)
to 7 (most severe). Symptoms were defined as: no symptoms (no
symptoms reported); mild (mild symptoms, weekly); moderate
(mild symptoms daily or severe symptoms weekly); and severe
(severe symptoms daily).
Data analysis
All 24-h MII-pH tracings were manually analyzed for the number
of GBs and SGBs according to previously described criteria.15 In
short, GBs were defined as a rapid retrograde rise in impedance of
>3000 O in at least two consecutive impedance channels reaching
the most proximal impedance channel. SGBs were defined by
rapid, non-peristaltic, antegrade entry of air into the esophagus
(increase in baseline impedance of >1000 O), directly followed by
quick expulsion of air (Fig. 1). The 24-h MII-pH tracings were
further evaluated for air swallows, acid exposure time, and the
number and content of liquid-containing reflux episodes accord-
ing to international accepted definitions.25 Pathologic acid expo-
sure time was defined as pH <4 during >6.0% of time during 24-h
monitoring.26,27
Ethical approval and trial registration
This study was registered in the Dutch national trial registry
(www.trialregister.nl; Identifier: 2934). Ethical approval for this
prospective multicenter study was obtained from the UMC
Utrecht Ethics Committee and local approval was obtained by
the remaining participating centers. Prior to initiating any trial-
related study procedure, informed consent from the patients’
parents was obtained.
Statistical analysis
Continuous parametric variables were expressed as mean  stan-
dard error of the mean (SEM). Non-parametric variables were
expressed as median, with interquartile ranges (IQR). Exploratory
subgroups analyses for all outcome measures were performed
comparing type of fundoplication and neurodevelopment and
using a paired sample T-test for continuous parametric outcomes
and the Wilcoxon signed rank test for non-parametric outcomes.
Correlations between different parameters were calculated using
the Pearson correlation coefficient or Spearman’s rank correlation
coefficient as appropriate. Linear regression analysis was per-
formed to identify possible determinants of the effect of LARS on
belching. Determinants of interest included: age, type of fundo-
plication, neurologic development, and the number of air swal-
lows. A p-value below 0.05 was considered statistically
significant. All statistical analyses were performed using com-
mercially available computer software (IBM SPSS Statistics for
Windows, Version 22; IBM Corp., Armonk, NY, USA).
RESULTS
In total 18 Thal and 7 Nissen fundoplications were
performed. In all patients fundoplication could be
completed by laparoscopy. Perioperative or postopera-
tive complications were not observed.
Preoperative 24-h pH-MII tracings were completed
in all 25 patients. After surgery, 24-h MII-pH monitor-
ing was successfully completed in 23 of 25 children. In
two patients postoperative tracings could not be
performed due to refusal by the caregivers. The care-
givers of one of these two patients also did not fill out
the postoperative symptom questionnaires. Both
patients were left out of the analysis.
Table 1 Baseline characteristics
Median (IQR) or n (%)
Age at time of operation (years) 6.0 (3.0–11.0)
Duration of hospital admission (days) 3.0 (2.0–4.5)
Male gender 12 (48.0)
Impaired neurodevelopment 5 (20.0)
 Charge syndrome
 Mitochondrial complex II deficiency
 Post-hypoxic encephalopathy
 Congenital rubella infection
 Impaired neurodevelopment of unknown
origin with autistic behavior
IQR, interquartile range.
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Reflux control
LARS successfully reduced the number of reflux
episodes and thereby decreased esophageal acid expo-
sure time (Table 2). Both pure liquid and mixed
(liquid and gas) reflux episodes were significantly
reduced after LARS (Table 2). In one patient with
retching based on impaired neurodevelopment a redo-
fundoplication was indicated because of severe recur-
rent reflux (pathological reflux on 24-h pH monitoring
and severe reflux symptoms) caused by hiatal herni-
ation.
Belching
Before LARS, GBs were frequently observed in all
pediatric GERD patients. Approximately half of these
GBS were directly followed by or occurred during a
reflux episode (Table 3). The total number of GBs was
significantly reduced after LARS (59 [43–77]VS 5 [2–12],
p < 0.001) (Table 3). In three patients GBs were no
longer identified on postoperative 24-h pH-MII tracings
(Fig. 2). SGBs occurred infrequently both before and
after LARS and no change in the number of SGBs was
found (Table 3). However, in one child the number of
SGBs increased up to over 170 SGBs per day (Fig. 3).
Nonetheless, this patient had no complaints of belching
after LARS.
Symptomatic belching significantly decreased after
LARS (Table 4). Postoperative belching symptoms
were correlated with the number of GBs (r: 0.53,
p < 0.01), not with SGBs (r: 0.35, NS). Furthermore,
patients who reported moderate-to-severe belching
symptoms after the procedure showed a trend toward
more GBs when compared to patients without or with
only mild belching symptoms (resp. 9 [4–26] VS 4 [0–7],
p = 0.06), but a similar low number of SGBs (resp. 2 [0–
4] VS 1 [0–4], NS).
Impact of type of fundoplication and
neurodevelopment on belching
To explore the possible differences between types of
fundoplication used in this study, patients were
divided into two groups: one group that had undergone
a partial (Thal) fundoplication (n = 17) and one group
that had undergone a complete (Nissen) fundoplication
(n = 6). Gastric belches decreased significantly after
both partial (from 66 [45–87) to 5 [2–12], p < 0.001) and
complete (from 44 [37–57] to 7 [4–15], p = 0.03) fundo-
plication. The reduction in GBs after partial fundopli-
cation (55 [74, 41]) and complete fundoplication
(36 [51,25]) was not significantly different
(p = 0.14). Also the number of postoperative GBs
(partial: 5 [2–12] vs complete: 7 [4–15], p = 0.18), SGBs
(partial: 2 [0–5] vs complete: 3 [0–4], p = 0.37), and
severity of postoperative belching symptoms (partial: 2
[0–49] VS 5 [0–11], p = 0.84) were not different between
partial and complete fundoplication.
10 000 Ω
0.5 s 0.5 s
10 000 Ω  
Figure 1 Examples of gastric belch (left
panel) and supragastric belch (right panel) on
24-h MII-pH tracing. Arrows indicate air
flow.









52.4  2.6 49.0  1.7
Acid exposure
time (%, IQR)
8.5 (6.0–16.2) 0.8 (0.2–2.8) <0.001
Upright (%, IQR) 12.1 (4.8–19.2) 1.8 (0.5–5.9) 0.001
Supine (%, IQR) 7.1 (0.9–15.3) 0 (0–0) <0.001
Total GER episodes
(n, IQR)
92 (66–139) 14 (11–22) <0.001
Liquid reflux 51 (40–93) 10 (5–19) <0.001
Mixed reflux 38 (21–50) 3 (1–8) <0.001
IQR, interquartile range; LARS, laparoscopic antireflux surgery.
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Patients with impaired neurodevelopment (NI;
n = 5) and normal neurodevelopment (NN; n = 18)
were also compared with respect to pre- and postoper-
ative GBs and SGBs. No significant differences were
observed between the two groups with respect to
preoperative GBs (NI: 70 [54–94] vs NN: 50 [42–72]),
preoperative SGBs (NI: 7 [6–8] vs NN: 1 [0–4], postop-
erative GBs (NI: 6 [4–28] vs NN: 5 [1–10]), and
postoperative SGBs (NI: 2 [2–3] vs NN: 2 [0–5]).
Predictors for the effect of LARS on belching
A linear regression analysis was performed to explore
determinants of the effect of LARS on gastric and
supragastric belching. No significant predictor (includ-
ing type of fundoplication and neurodevelopment) was
identified predicting the effect of LARS on the number
of gastric and supragastric belching (data not shown).
Linear regression analysis, however, did identify the
number of preoperative air swallows as a determinant
positively influencing the number of preoperative
gastric belching (b: 0.24; 95% CI: 0.04–0.44, p = 0.03).
After fundoplication, however, the number of air
swallows was not associated with the number of
postoperative belches. Nonetheless, postoperative
gastric belches were associated with postoperative
belching symptoms (b: 0.43; 95% CI: 0.06–0.80,
p = 0.04), as previously established. All other determi-
nants of interest did not show any significant effect on
the effect of LARS on belching and the total number of
belches before and after LARS.
DISCUSSION
This is the first study that explores the effect of LARS
on belching in pediatric GERD patients. The main
findings were that belching symptoms and number of
GBs significantly decreased after LARS, but LARS did
not affect the number SGBs.
In previous studies, it has been reported that 19% of
pediatric patients are unable to belch and up to 11%
suffer from gas-bloat syndrome after LARS.18–20
Although it is generally accepted that these symptoms
arise from accumulation of intragastric air as a conse-
quence of an inability to belch, the substantial reduc-
tion in the number of GBs after LARS as observed in
this study provides objective data supporting this
hypothesis on the pathogenesis of these postoperative
symptoms in children. These results are in line with
studies in adults, in whom a similar reduction in GBs
was observed after LARS.10–12
Table 3 Number of GB and the association with reflux episodes,
supragastric belches, and air swallows during 24-h MII-pH monitoring
Preoperative Postoperative p-value
Gastric belches (total) 59 (43–77) 5 (2–12) <0.001
GB alone 30 (14–53) 4 (1–8) <0.001
GB during reflux 5 (2–9) 0 (0–1) <0.001
GB prereflux 19 (10–26) 1 (0–2) <0.001
Supragastric belches 2 (0–7) 2 (0–4) NS
Air swallows 39 (29–65) 43 (28–83) NS
GB, gastric belch; MII-pH, multichannel intraluminal impedance-pH.
Figure 2 Pre- and postoperative number of gastric belches for each
individual patient on 24-h MII-pH monitoring. *p < 0.001.
Figure 3 Pre- and postoperative number of supragastric belches for
each individual patient on 24-h MII-pH monitoring.
Table 4 Assessment of symptomatic belching: number of patients and







None 5 (21) 9 (37) 0.007
Mild 3 (13) 7 (29)
Moderate 8 (33) 5 (21)
Severe 8 (33) 3 (13)
LARS, laparoscopic antireflux surgery.
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The mechanism through which LARS leads to a
reduction in GBs was previously thought to be due to
the reduction in TLESRs after LARS.10 GBs are medi-
ated mainly by TLESRs, which allow gastric air to
escape from the stomach into the esophagus. Conse-
quently, by relaxation of the upper esophageal sphinc-
ter air passes into the pharynx and mouth.2,3,28
Previously, several studies have shown that the num-
ber of TLESRs is significantly reduced after LARS.8,9
This reduction in TLESRs correlated with impaired
gastric belching and consequently led to gas-related
complications after LARS.10 In the current protocol,
assessment of the effect of LARS on TLESRs and their
association with belching was not included. We,
however, speculate that similar to adults, the reduc-
tion in TLESRs is mainly responsible for the decrease
in GBs. The reduction in GBs cannot be explained by a
change in air swallowing, as the number of air swal-
lows after LARS remained unchanged. This is similar
to data in adult studies on belching patterns after
LARS.11,12 The number of air swallows was, however,
lower in pediatric GERD patients compared to the
adult GERD patients, although comparable to the rate
of air swallows previously reported in healthy chil-
dren.29
Supragastric belching was not frequently observed
and no shift in belching patterns from gastric to
supragastric belching occurred in pediatric GERD
patients. This is in contrast to findings from two
studies in adults, in which the number of SGBs
increased and caused a higher number of postopera-
tive belching symptoms.11,12 In contrast, in children
postoperative belching symptoms decreased and
remaining belching symptoms after LARS correlated
with GBs but not with SGBs. The number of SGBs in
the current population was relatively low compared to
findings from adult studies.11,12 The current results
suggest that supragastric belching plays no significant
role in pediatric GERD patients. However, further
studies are needed to support and confirm this
statement, as up to now no studies have been
performed to assess the relationship between supra-
gastric belching and GERD specifically and more in
general, gas-related complaints and objectively iden-
tified abnormalities such as supragastric belching or
aerophagia in children.
Nevertheless, excessive supragastric belching after
LARS may occur, as we observed in a single patient.
This specific child exhibited autistic behavior with
impaired neurodevelopment that may have (at least
partly) contributed to this abnormal belching pattern
after LARS.
In this study, two types (partial and complete) of
fundoplication were performed that may have a
different effect on belching. In a study on belching
after LARS in adult GERD patients, with aerophagia
as comorbidity, the gas-related symptomatic outcome
of partial fundoplication was superior to complete
fundoplication.30 This finding is in line with several
studies and meta-analyses showing favorable out-
comes of partial fundoplication compared to com-
plete fundoplication with regard to gas-related
complications of LARS.10,12–14 We performed an
exploratory comparison between the effects of the
different types of fundoplication, showing no appar-
ent advantage comparing complete-to-partial fundo-
plication in maintaining the ability to belch.
However, it has to be noted that this study was not
powered to answer this question. Therefore, future
studies, preferably in the form of a randomized
controlled trial, should be performed to give more
conclusive answers.
Another issue that needs to be considered regard-
ing the conclusions of this study is that a 3-month
follow-up is relatively short as impaired belching
may improve over a longer period of time. Allal
et al. previously described that after 10 months gas
bloating had resolved completely, but three patients
with severe complaints required placement of a
gastric tube in their study. Moreover, other studies
have reported gas-related complications in a sub-
stantial proportion of children several years after
LARS.18,31 Lastly, although this study provides
objective evidence for intragastric gas accumulation,
we have no data to support the assumption that
intragastric gas accumulation leads to gas-bloat
symptoms and hyperflatulence as frequently reported
after fundoplication.
In conclusion, gastric belching is significantly
reduced after LARS, whereas the number of air swal-
lows remains unchanged. This is likely to explain
frequently reported postoperative gas-related compli-
cations (gas bloat and the inability to belch) of LARS in
children. Supragastric belches occurred infrequently
and the number of SGBs was not altered after LARS.
Additional studies on the evolution of gas-related
complications during long-term follow-up and possible
differences between commonly used surgical tech-
niques are needed.
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